Tempus, a provider in artificial intelligence (AI) and precision medicine, has entered a multi-year, strategic collaboration with Pfizer to further AI and machine learning-driven efforts in therapeutic development. The collaboration aims to more precisely gather insights that will inform novel drug discovery and development in oncology.   Through this collaboration, Pfizer has access to Tempus’ AI-enabled platform and its library of de-identified, multimodal data to uncover insights for therap...